Literature DB >> 33735307

The granuloma in cryptococcal disease.

Laura C Ristow1, J Muse Davis1.   

Abstract

Although we have recognized cryptococcosis as a disease entity for well over 100 years, there are many details about its pathogenesis which remain unknown. A major barrier to better understanding is the very broad range of clinical and pathological forms cryptococcal infections can take. One such form has been historically called the cryptococcal granuloma, or the cryptococcoma. These words have been used to describe essentially any mass lesion associated with infection, due to their presumed similarity to the quintessential granuloma, the tubercle in tuberculosis. Although clear distinctions between tuberculosis and cryptococcal disease have been discovered, cellular and molecular studies still confirm some important parallels between these 2 diseases and what we now call granulomatous inflammation. In this review, we shall sketch out some of the history behind the term "granuloma" as it pertains to cryptococcal disease, explore our current understanding of the biology of granuloma formation, and try to place that understanding in the context of the myriad pathological presentations of this infection. Finally, we shall summarize the role of the granuloma in cryptococcal latency and present opportunities for future investigations.

Entities:  

Year:  2021        PMID: 33735307      PMCID: PMC7971563          DOI: 10.1371/journal.ppat.1009342

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  40 in total

Review 1.  Granulomatous inflammations.

Authors:  D L Boros
Journal:  Prog Allergy       Date:  1978

2.  Immunologic homeostasis during infection: coexistence of strong pulmonary cell-mediated immunity to secondary Cryptococcus neoformans infection while the primary infection still persists at low levels in the lungs.

Authors:  Dennis M Lindell; Megan N Ballinger; Roderick A McDonald; Galen B Toews; Gary B Huffnagle
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

Review 3.  Pulmonary infections mimicking cancer: a retrospective, three-year review.

Authors:  K V Rolston; S Rodriguez; N Dholakia; E Whimbey; I Raad
Journal:  Support Care Cancer       Date:  1997-03       Impact factor: 3.603

4.  Restraining mycobacteria: role of granulomas in mycobacterial infections.

Authors:  B M Saunders; A M Cooper
Journal:  Immunol Cell Biol       Date:  2000-08       Impact factor: 5.126

5.  Epidemiological evidence for dormant Cryptococcus neoformans infection.

Authors:  D Garcia-Hermoso; G Janbon; F Dromer
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

Review 6.  Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome.

Authors:  D H Mitchell; T C Sorrell; A M Allworth; C H Heath; A R McGregor; K Papanaoum; M J Richards; T Gottlieb
Journal:  Clin Infect Dis       Date:  1995-03       Impact factor: 9.079

7.  Characterization of pathogenic constituents of Cryptococcus neoformans strains.

Authors:  K Kagaya; T Yamada; Y Miyakawa; Y Fukazawa; S Saito
Journal:  Microbiol Immunol       Date:  1985       Impact factor: 1.955

8.  Serologic evidence for regional differences in pediatric cryptococcal infection.

Authors:  Jennifer Davis; Wang Yong Zheng; Aharona Glatman-Freedman; Josephine Anne Navoa Ng; Marimel R Pagcatipunan; Herschel Lessin; Arturo Casadevall; David L Goldman
Journal:  Pediatr Infect Dis J       Date:  2007-06       Impact factor: 2.129

9.  Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model.

Authors:  Rosemary Santangelo; Hans Zoellner; Tania Sorrell; Christabel Wilson; Christine Donald; Julianne Djordjevic; Yi Shounan; Lesley Wright
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

10.  Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Thailand display diverse phenotypic interactions with macrophages.

Authors:  Adithap Hansakon; Putthiphak Mutthakalin; Popchai Ngamskulrungroj; Methee Chayakulkeeree; Pornpimon Angkasekwinai
Journal:  Virulence       Date:  2019-12       Impact factor: 5.882

View more
  5 in total

1.  An Immunogenic and Slow-Growing Cryptococcal Strain Induces a Chronic Granulomatous Infection in Murine Lungs.

Authors:  Calla L Telzrow; Shannon Esher Righi; Natalia Castro-Lopez; Althea Campuzano; Jacob T Brooks; John M Carney; Floyd L Wormley; J Andrew Alspaugh
Journal:  Infect Immun       Date:  2022-05-19       Impact factor: 3.609

2.  Three Models of Vaccination Strategies Against Cryptococcosis in Immunocompromised Hosts Using Heat-Killed Cryptococcus neoformans Δsgl1.

Authors:  Tyler G Normile; Maurizio Del Poeta
Journal:  Front Immunol       Date:  2022-05-09       Impact factor: 8.786

3.  Missed opportunities to identify cryptococcosis in COVID-19 patients: a case report and literature review.

Authors:  Daniel B Chastain; Andrés F Henao-Martínez; Austin C Dykes; Gregory M Steele; Laura Leigh Stoudenmire; Geren M Thomas; Vanessa Kung; Carlos Franco-Paredes
Journal:  Ther Adv Infect Dis       Date:  2022-01-15

4.  Cryptococcosis in a patient with multiple myeloma receiving pomalidomide: a case report and literature review.

Authors:  Daniel B Chastain; Sahand Golpayegany; Andrés F Henao-Martínez; Brittany T Jackson; Laura Leigh Stoudenmire; Kaye Bell; Kayla R Stover; Carlos Franco-Paredes
Journal:  Ther Adv Infect Dis       Date:  2022-07-23

5.  Cryptococcosis among hospitalised patients with COVID-19: A multicentre research network study.

Authors:  Daniel B Chastain; Vanessa M Kung; Sahand Golpayegany; Brittany T Jackson; Carlos Franco-Paredes; Lilian Vargas Barahona; George R Thompson; Andrés F Henao-Martínez
Journal:  Mycoses       Date:  2022-06-19       Impact factor: 4.931

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.